You are required to be logged in to access the full website
Click here if you have forgotten your username or password
2 September 2026 - Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) on Wednesday reported positive top-line results from an ongoing Phase 2a study of TEV '408, an investigational anti-interleukin-15 m...
2 September 2026 - Japanese pharmaceutical company Ono Pharmaceutical Co Ltd (TYO:4528) said on Wednesday that it has entered into a drug discovery partnership with US biotechnology company Aitia Inc to identify new therapeutic targets and biomarkers...
2 September 2026 - Rare disease biotechnology company BioMarin Pharmaceutical Inc (Nasdaq:BMRN) confirmed on Tuesday that it has completed the acquisition of Alesta Therapeutics, a clinical-stage biotechnology company focused on developing novel oral...
2 September 2026 - Biotechnology company BioViva USA Inc announced on Tuesday the issuance of US Patent No. 12,564,646, titled 'Treatment of Age-Related Cognitive Decline Using Genetically Modified Viral Vectors'.This patent covers the use ...
1 September 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Tuesday it has completed its exclusive global licence agreement with China-based Dizal Pharmaceutical Co., Ltd (SSE: 688192) for Zegfrovy (sunvozerti...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe